Trexquant Investment LP

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1633445 STAMFORD, CT

Position in ANIP

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,643,378

+$444,100 QoQ

Shares Held

56,093

+2.7% QoQ

Ownership

0.244%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#77

of 303 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

Trexquant Investment LP holds $109,740,543 across 18 Drug Manufacturers - Specialty & Generic names. ANIP ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	676,544	$48,616,451
2	LQDA	Liquidia Corp	110,628	$8,820,370
3	HIMS	Hims & Hers Health, Inc.	233,191	$8,084,731
4	ELAN	Elanco Animal Health Inc	310,453	$7,640,248
5	AMLX	Amylyx Pharmaceuticals, Inc.	349,439	$6,275,924
6	PRGO	PERRIGO Co plc	542,952	$5,641,271
7	ANIP	Ani Pharmaceuticals Inc This page	56,093	$4,643,378
8	EBS	Emergent BioSolutions Inc.	447,858	$3,753,050

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,643,378	56,093	+2.7%	Shares	Sole	2026-08-14
2026-03-31	$4,199,278	54,607	-19.0%	Shares	Sole	2026-05-15
2025-12-31	$5,320,398	67,398	+22.8%	Shares	Sole	2026-02-17
2025-09-30	$5,027,466	54,885	+12.4%	Shares	Sole	2025-11-14
2025-06-30	$3,185,570	48,821	+191.1%	Shares	Sole	2025-08-12
2024-06-30	$1,068,040	16,772	-64.4%	Shares	Sole	2024-08-13
2024-03-31	$3,259,272	47,147	+65.5%	Shares	Sole	2024-05-14
2023-12-31	$1,570,607	28,484	-34.6%	Shares	Sole	2024-02-09
2023-09-30	$2,527,119	43,526	+14.8%	Shares	Sole	2023-11-13
2023-06-30	$2,041,179	37,919	+362.1%	Shares	Sole	2023-08-11
2023-03-31	$325,942	8,206	-19.5%	Shares	Sole	2023-05-15
2021-12-31	$469,969	10,199	+44.5%	Shares	Sole	2022-02-14
2020-12-31	$204,993	7,059	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.